Recently, our group has found that the expression level of USP37 is exceptionally upregulated in CD44+/CD24- phenotype breast cancer stem cells, and can regulate the stemness of breast cancer cell through its interaction with GLI-19. The gene discussed is USP37; the disease is breast cancer.